The launch of BrightMeds GLP-1 marks a crucial shift in how physicians handle type 2 diabetes . This new medication class offers a different mechanism of action that not only reduces blood glucose levels but also encourage weight loss and boost heart outcomes. Early results suggest it could be a a powerful tool for people needing better sustained c